Parkinson's disease is a degenerative neurological disease of unknown origin. Certain nerve cells in the brain, in particular the cells that produce the messenger dopamine, die off and cause the slow development of four main symptoms of varying severity:
-
Bradykinesia (slowing of movement)
-
Rigidity (stiffness, increase in muscle tension, incorrect activation of muscles)
-
Tremor (shaking: involuntary, rhythmical, repeated movements)
-
Postural instability (lack of stability when upright)
It is estimated that approx. 250,000 to 400,000 people currently suffer from so-called idiopathic Parkinson's disease (IPS) in Germany. This disease occurs more frequently when we are older. As the average age of the population is continually increasing, this means that the number of patients will also continue to increase.
The therapy principles are based on physical therapy to maintain motor functional abilities, individual drug therapy to improve mobility and balance out the dopamine deficiency, the targeted reduction of the risks linked to the disease (e.g., risk of falls, swallowing disorders), and the individual treatment in advanced stages of the disease using technical or pump-assisted forms of therapy such as apomorphine pumps, duodopa pumps and deep brain stimulation